107 related articles for article (PubMed ID: 15901882)
21. Time pattern of exercise-induced changes in type I collagen turnover after prolonged endurance exercise in humans.
Langberg H; Skovgaard D; Asp S; Kjaer M
Calcif Tissue Int; 2000 Jul; 67(1):41-4. PubMed ID: 10908411
[TBL] [Abstract][Full Text] [Related]
22. Exercise-dependent IGF-I, IGFBPs, and type I collagen changes in human peritendinous connective tissue determined by microdialysis.
Olesen JL; Heinemeier KM; Gemmer C; Kjaer M; Flyvbjerg A; Langberg H
J Appl Physiol (1985); 2007 Jan; 102(1):214-20. PubMed ID: 16973813
[TBL] [Abstract][Full Text] [Related]
23. Type I collagen synthesis and degradation in peritendinous tissue after exercise determined by microdialysis in humans.
Langberg H; Skovgaard D; Petersen LJ; Bulow J; Kjaer M
J Physiol; 1999 Nov; 521 Pt 1(Pt 1):299-306. PubMed ID: 10562353
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of work-related musculoskeletal disorders among Egyptian printing workers evidenced by using serum biomarkers of inflammation, oxidative stress, muscle injury, and collagen type I turnover.
Mourad BH
Toxicol Ind Health; 2021 Jan; 37(1):9-22. PubMed ID: 33295250
[TBL] [Abstract][Full Text] [Related]
25. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients.
Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273
[TBL] [Abstract][Full Text] [Related]
26. [Clinical usefulness of blood PICP, PINP and ICTP concentrations as bone metastasis markers in prostate cancer patients].
Kobayashi Y; Tokue A
Nihon Rinsho; 1998 Aug; 56(8):2072-6. PubMed ID: 9750510
[TBL] [Abstract][Full Text] [Related]
27. Use of a marker of collagen formation in osteoporosis studies.
Risteli J; Melkko J; Niemi S; Risteli L
Calcif Tissue Int; 1991; 49 Suppl():S24-5. PubMed ID: 1933592
[TBL] [Abstract][Full Text] [Related]
28. Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover.
Tokita A; Kelly PJ; Nguyen TV; Qi JC; Morrison NA; Risteli L; Risteli J; Sambrook PN; Eisman JA
J Clin Endocrinol Metab; 1994 Jun; 78(6):1461-6. PubMed ID: 8200950
[TBL] [Abstract][Full Text] [Related]
29. Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.
Olsen MH; Christensen MK; Wachtell K; Tuxen C; Fossum E; Bang LE; Wiinberg N; Devereux RB; Kjeldsen SE; Hildebrandt P; Dige-Petersen H; Rokkedal J; Ibsen H
J Hum Hypertens; 2005 Apr; 19(4):301-7. PubMed ID: 15647776
[TBL] [Abstract][Full Text] [Related]
30. [Measurements and clinical usefulness of carboxyterminal propeptide of type I collagen and cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer].
Igawa T; Sakai H; Kanetake H; Saito Y
Hinyokika Kiyo; 1999 Apr; 45(4):235-9. PubMed ID: 10363141
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure.
Löfsjögård J; Kahan T; Díez J; López B; González A; Edner M; Henriksson P; Mejhert M; Persson H
J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):463-9. PubMed ID: 24983265
[TBL] [Abstract][Full Text] [Related]
32. Type I collagen and procollagen fragments in patients with metabolic bone diseases.
Lin JS; Kao JT; Tsai KS
J Formos Med Assoc; 1996 Jul; 95(7):523-9. PubMed ID: 8840753
[TBL] [Abstract][Full Text] [Related]
33. Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis.
Sassi ML; Aman S; Hakala M; Luukkainen R; Risteli J
Clin Chem Lab Med; 2003 Aug; 41(8):1038-44. PubMed ID: 12964811
[TBL] [Abstract][Full Text] [Related]
34. Intra-individual variation in serum type I procollagen carboxy-terminal propeptide and type I collagen carboxy-terminal cross-linked telopeptide concentrations.
Stevenson HP; Leslie H; Sheridan B
Ann Clin Biochem; 1997 May; 34 ( Pt 3)():317-8. PubMed ID: 9158832
[No Abstract] [Full Text] [Related]
35. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
[TBL] [Abstract][Full Text] [Related]
36. Systemic cross-linked N-terminal telopeptide and procollagen I C-terminal extension peptide as markers of bone turnover after total hip arthroplasty.
Savarino L; Granchi D; Cenni E; Baldini N; Greco M; Giunti A
J Bone Joint Surg Br; 2005 Apr; 87(4):571-6. PubMed ID: 15795214
[TBL] [Abstract][Full Text] [Related]
37. Comparison of bone resorption markers during hypocalcemia in dairy cows.
Liesegang A; Sassi ML; Risteli J; Eicher R; Wanner M; Riond JL
J Dairy Sci; 1998 Oct; 81(10):2614-22. PubMed ID: 9812267
[TBL] [Abstract][Full Text] [Related]
38. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.
Sharif M; Kirwan J; Charni N; Sandell LJ; Whittles C; Garnero P
Rheumatology (Oxford); 2007 Jun; 46(6):938-43. PubMed ID: 17387119
[TBL] [Abstract][Full Text] [Related]
39. Plasma and tissue levels of collagen types I and III markers in patients with abdominal aortic aneurysms.
Treska V; Topolcan O
Int Angiol; 2000 Mar; 19(1):64-8. PubMed ID: 10853688
[TBL] [Abstract][Full Text] [Related]
40. Osteocartilaginous metabolic markers change over a 3-week stage race in pro-cyclists.
Corsetti R; Perego S; Sansoni V; Xu J; Barassi A; Banfi G; Lombardi G
Scand J Clin Lab Invest; 2015 Oct; 75(6):523-30. PubMed ID: 26174975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
